Moderna CEO's big payout; patients scramble for treatment after ketamine clinic closures

Taking stock of the drug industry, from the lab to the medicine chest

March 17, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

JOEL SAGET/AFP via Getty Images STAT+ | Moderna CEO made $398 million in 2022, but still pledges to give most to charity Moderna CEO Stéphane Bancel made almost $400 million in 2022, although nearly all of that remains earmarked for unknown charities. By Bob Herman and Damian Garde 'I'm terrified': Patients scramble for treatment after 13 ketamine clinics shut down Behind the scenes of a business deal that appears to have gone terribly awry, leaving behind patients who relied on ketamine clinics. By Isabella Cueto STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman Christopher Michel/Wikimedia Commons JAMA's new editor settles in, bringing open access and other changes "We are asking ourselves what are the issues at the forefront of medicine and how does JAMA ... bring those issues to light for our readers?" By Usha Lee McFarling

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser